We are seeking a Regional Commercial Head EMEA for our headquarters in Geneva. Reporting to the Chief Commercial Officer, you will lead a team of two and focus on expanding our sales throughout the EMEA region. Your responsibilities include strengthening existing partnerships, forming new ones, and identifying business opportunities within the area. Collaboration with internal teams such as Alliance Management & Partnering, Global Medical Affairs, Global Marketing, and Customer Operations is essential for your success.
Your main tasks include:
The role requires business travel between 20% and 40% of your working time.
To succeed, we are looking for a dynamic, entrepreneurial candidate with the following qualifications:
You are creative and solution-oriented, skilled at convincing and influencing others. You excel in building trust and enthusiasm among colleagues and partners. Your negotiation abilities and strategic mindset help you achieve results in diverse cultural settings. With excellent communication, interpersonal, and leadership skills, you adapt quickly to new environments and foster collaboration across departments.
If you’re ready to shape strategy at the regional level—from definition to implementation—apply now!
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases.
It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections.
The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.
For more information, visit the website: ompharma.com

We use our expertise in bacterial lysates to address the world’s most significant health challenges from the rise in infectious disease outbreaks to antimicrobial resistance.
Currently active in the prevention of respiratory and urinary tract infections, our constantly evolving understanding of how bacterial lysates interact with the immune system motivates us to invest in new indications and new formulations for our lysates.
Headquartered in Geneva with affiliates in Peru and Switzerland, our products are available in more than 100 countries through a network of trusted partners.